Summary by Futu AI
Novo Nordisk A/S, a leading global healthcare company, has announced the progress of its share repurchase program on August 26, 2024. The program, which began on February 6, 2024, aims to repurchase up to DKK 20 billion worth of shares over a 12-month period. As part of this initiative, a specific share repurchase plan was initiated on August 7, 2024, targeting the repurchase of B shares for an amount up to DKK 2.4 billion, to be completed by November 4, 2024. Since the last update on August 19, 2024, Novo Nordisk has acquired an additional 205,000 B shares at an average price of approximately DKK 914.16, amounting to a transaction value of DKK 187,386,081. This brings the total repurchased under the program to 540,187 B shares, with an accumulated transaction value of DKK 485,999,068. The company...Show More